-transparent.png){kind=logo}
A useful pharmaceutical intermediate, 5-nitromethyl-1-azabicyclo[3.3.0]octane (1), was prepared in one step from 1,7-dichloro-4-heptanone (4) under mild conditions. Catalytic hydrogenation of 1 over Raney Ni in the presence of sodium hydroxide afforded 5-aminomethyl-1-azabicyclo[3.3.0]octane (2) in high yield. Piracetam analogues 20-23, which were pyrrolidine derivatives involving a 1-azabicyclo[3.3.0]octane ring, were synthesized. Pharmacological tests showed that N-[(1-azabicyclo[3.3.0]octan-5-yl)methyl]-2-oxo-1-pyrrolidineacetamid e (20) improves cerebral function.
Related Publications
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
January 1999,
Chemical & pharmaceutical bulletin,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
February 2001,
Organic letters,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
May 1976,
Chemical & pharmaceutical bulletin,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
January 2007,
Bioorganic & medicinal chemistry letters,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
August 1998,
Chemical & pharmaceutical bulletin,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
June 2010,
Bioorganic & medicinal chemistry letters,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
June 1999,
Chemical & pharmaceutical bulletin,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
August 2003,
Chemical & pharmaceutical bulletin,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
June 1965,
Il Farmaco; edizione scientifica,
M Oka, and
Y Matsumoto, and
K Hirooka, and
T Suzuki
May 2000,
Journal of natural products,
